Israel Englander Axcella Health Inc. Transaction History

Millennium Management LLC

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$0.22 - $0.46 $10,375 - $21,694	-47,161 Reduced 39.48%	72,281 $15,000
Q1 2023 May 15, 2023	BUY	$0.31 - $0.77 $6,845 - $17,003	22,083 Added 22.68%	119,442 $57,000
Q4 2022 Feb 14, 2023	BUY	$0.16 - $1.1 $15,577 - $107,094	97,359 New	97,359 $32,000
Q2 2022 Aug 15, 2022	SELL	$1.41 - $2.77 $56,192 - $110,392	-39,853 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$1.58 - $2.82 $9,162 - $16,353	-5,799 Reduced 12.7%	39,853 $102,000
Q4 2021 Feb 14, 2022	SELL	$2.06 - $3.61 $1,353 - $2,371	-657 Reduced 1.42%	45,652 $95,000
Q3 2021 Nov 15, 2021	SELL	$2.98 - $4.31 $138,209 - $199,893	-46,379 Reduced 50.04%	46,309 $138,000
Q2 2021 Aug 16, 2021	BUY	$3.08 - $5.13 $243,470 - $405,521	79,049 Added 579.58%	92,688 $372,000
Q1 2021 May 17, 2021	SELL	$4.55 - $6.72 $11,406 - $16,847	-2,507 Reduced 15.53%	13,639 $65,000
Q4 2020 Feb 16, 2021	SELL	$4.24 - $5.97 $52,338 - $73,693	-12,344 Reduced 43.33%	16,146 $84,000
Q3 2020 Nov 16, 2020	SELL	$4.12 - $5.91 $84,517 - $121,237	-20,514 Reduced 41.86%	28,490 $132,000
Q2 2020 Aug 14, 2020	BUY	$2.94 - $7.7 $144,071 - $377,330	49,004 New	49,004 $271,000
Q4 2019 Feb 14, 2020	SELL	$3.08 - $5.9 $208,787 - $399,949	-67,788 Closed	0 $0
Q3 2019 Nov 14, 2019	SELL	$5.25 - $9.26 $103,797 - $183,079	-19,771 Reduced 22.58%	67,788 $383,000
Q2 2019 Aug 15, 2019	SELL	$8.51 - $14.95 $2.23 Million - $3.91 Million	-261,482 Reduced 74.91%	87,559 $815,000
Q2 2019 Aug 14, 2019	BUY	$8.51 - $14.95 $2.97 Million - $5.22 Million	349,041 New	349,041 $2.04 Million

61.6K

Ticker AXLA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 73,500,896
Description
Axcella Health Inc. operates as a clinical stage biotechnology company in the United States. The company treats complex diseases and enhances health using endogenous metabolic modulator compositions. Its lead product candidates include AXA1665, which is in Phase 2 clinical trial for the reduction in risk of overt hepatic encephalopathy recurrenc...

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.